Director Share Purchase
Updated : 14:51
12 May 2021
Kromek Group plc
("Kromek" or the "Group")
Director Share Purchase
Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that Rakesh Sharma, Non-Executive Chairman, has today purchased 63,152 ordinary shares of 1 pence each in the Group ("Ordinary Shares") at a price of 15.83 pence per Ordinary Share.
Following this purchase, Mr Sharma has an interest in 374,856 Ordinary Shares, representing 0.09% of the issued share capital of the Group.
For further information, please contact:
Kromek Group plc |
|
Arnab Basu, CEO Paul Farquhar, CFO
| +44 (0)1740 626 060 |
Cenkos Securities plc (Nominated Adviser and Broker) |
|
Max Hartley/Camilla Hume (NOMAD) Julian Morse (Sales)
| +44 (0)20 7397 8900 |
Luther Pendragon (PR) |
|
Harry Chathli/Claire Norbury | +44 (0)20 7618 9100 |
About Kromek Group plc
Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over 150 full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
The Group makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Rakesh Sharma | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-Executive Chairman | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Kromek Group plc | ||||
b) | LEI | 213800VLHYXGHEX5VQ48 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 1p each
GB00BD7V5D43 | ||||
b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d) | Aggregated information - Aggregated volume |
N/A | ||||
e) | Date of the transaction | 12 May 2021 | ||||
f) | Place of the transaction | London Stock Exchange |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.